Background and purpose: Flattening filter free (FFF) beams enable high-dose rate irradiations and have the potential to speed up breast cancer radiotherapy (RT) treatments. In this work the surface doses of FFF beams were studied with various treatment plans for breast cancer RT. The near surface dose distributions were compared to the ones delivered with conventional flattening filter (FF) beams and to the calculated dose distributions. Materials and methods: The study was executed with radiochromic films. In addition to one open field, four techniques were investigated: tangential open field, tangential IMRT (IMRT), tangential VMAT (tVMAT) and continuous VMAT (cVMAT) techniques, respectively. The dose distributions were calculated with commercial Monte Carlo (MC) algorithm with energies of 6 and 10 MV with both FF and FFF. The surface areas investigated were divided into depths of 0-2, 2-5 and 5-8 mm. Results: The largest deviations (on average 5.9%) between the measured and calculated doses were recorded at the most shallowest depths (0-2 mm). At deeper depths, the differences were on average 1.4% and always less than 6%. The measured near surface doses were slightly lower (4.6%) with modulated 6MVFFF beams than with the corresponding flattened beams and on the contrary with 10 MV the surface doses by FFF were slightly higher (2.8%). Conclusions: The studied MC calculation algorithm was accurate in determine the near surface doses. There was no significant difference in measured or calculated surface doses between FFF and FF beams. With respect to surface dose uniformity the VMAT techniques overall resulted in the most uniform dose distributions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.